{
  "type": "hyp",
  "text": "Two clones were obtained in which the loss of NF-kappaB binding activity correlated with the constitutive expression of the transgenic IkappaBalpha. IkappaBalpha ubiquitination was inhibited by the proteasome inhibitor N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal or transient overexpression of mutant IkappaBalpha.\n",
  "self": {
    "NER": {
      "answers": [
        "Two",
        "IkappaBalpha",
        "IkappaBalpha",
        "IkappaBalpha"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many clones were obtained in which the loss of NF-kappaB",
          "What protein was mutated in the clones?",
          "What protein was mutated in the clones?",
          "What protein was mutated in the clones?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Two clones",
        "the loss",
        "NF-kappaB binding activity",
        "the constitutive expression",
        "the transgenic IkappaBalpha",
        "IkappaBalpha ubiquitination",
        "the proteasome inhibitor",
        "L-leucinyl",
        "mutant IkappaBalpha"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many clones were obtained in which the loss of NF-kappaB",
          "What was the result of the two clones obtained?",
          "What was lost in the two clones obtained?",
          "What did the loss of NF-kappaB binding activity correlate with?",
          "What protein was expressed in the two clones?",
          "What was inhibited by the proteasome inhibitor?",
          "What inhibited ubiquitination of IkappaBalpha?",
          "What is the name of the proteasome inhibitor that inhibits ubiquitination of",
          "What protein was overexpressed?"
        ]
      }
    }
  },
  "asked": {
    "What protein was not altered by age?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0027605295181274414,
        "ground_truth": {
          "IkappaBalpha": {
            "bertscore": 0.6275320649147034,
            "f1": 0
          }
        }
      }
    },
    "What did not show any significant age-related alterations?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00036215782165527344,
        "ground_truth": {
          "Examination": {
            "bertscore": 0.6870423555374146,
            "f1": 0
          }
        }
      }
    },
    "What did the study not show any significant age-related alterations?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00020653009414672852,
        "ground_truth": {
          "activation-induced phosphorylation": {
            "bertscore": 0.6046730875968933,
            "f1": 0
          }
        }
      }
    },
    "What is the main component of IkappaBalpha?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.06707054376602173,
        "ground_truth": {
          "ubiquitination": {
            "bertscore": 0.6691908240318298,
            "f1": 0
          }
        }
      }
    },
    "What did the examination of activation-induced phosphorylation and ubiquitination": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.025556743144989014,
        "ground_truth": {
          "any significant age-related alterations": {
            "bertscore": 0.6551451086997986,
            "f1": 0
          }
        }
      }
    }
  }
}